+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Chondroitin Sulfate Market Report and Forecast 2023-2031 - Product Thumbnail Image

Chondroitin Sulfate Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Psoriatic Arthritis Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Psoriatic Arthritis Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Alopecia Market Report and Forecast 2023-2031 - Product Thumbnail Image

Alopecia Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Plaque Psoriasis Treatment Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Plaque Psoriasis Treatment Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Allergic Conjunctivitis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Allergic Conjunctivitis Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Wegener's Granulomatosis Treatment Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Wegener's Granulomatosis Treatment Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Transplant Immunosuppressive Drug Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Transplant Immunosuppressive Drug Market - Forecasts from 2023 to 2028

  • Report
  • June 2023
  • 113 Pages
  • Global
From
Immunosuppressant Drugs Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Immunosuppressant Drugs Market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 145 Pages
  • Global
From
Research Antibodies Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Research Antibodies Market - Forecasts from 2024 to 2029

  • Report
  • May 2024
  • 124 Pages
  • Global
From
Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
Monoclonal Antibodies Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Monoclonal Antibodies Market - Forecasts from 2022 to 2027

  • Report
  • December 2022
  • 142 Pages
  • Global
From
Aspirin Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Aspirin Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 140 Pages
  • Global
From
Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type [Type 1 Collagen and Hyaluronic Acid], End User, and Country - Product Thumbnail Image

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type [Type 1 Collagen and Hyaluronic Acid], End User, and Country

  • Report
  • October 2024
  • 92 Pages
  • Europe
From
India Lymphedema Treatment Market Forecast 2020-2030, and Country Share, Trend, and Growth Opportunity Analysis Coverage: Condition Type, Treatment Type, and End User - Product Thumbnail Image

India Lymphedema Treatment Market Forecast 2020-2030, and Country Share, Trend, and Growth Opportunity Analysis Coverage: Condition Type, Treatment Type, and End User

  • Report
  • October 2023
  • 85 Pages
  • India
From
North America Intravenous Immunoglobulin Market Size and Forecasts 2020-2030, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, Distribution Channel, End User, and Country - Product Thumbnail Image

North America Intravenous Immunoglobulin Market Size and Forecasts 2020-2030, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type, Application, Distribution Channel, End User, and Country

  • Report
  • October 2023
  • 107 Pages
  • North America
From
US Lymphedema Treatment Market Forecast to 2028 - Country Analysis By Condition Type, Treatment Type, and End User - Product Thumbnail Image

US Lymphedema Treatment Market Forecast to 2028 - Country Analysis By Condition Type, Treatment Type, and End User

  • Report
  • May 2023
  • 132 Pages
  • United States
From
US Intravenous Immunoglobulin Market Forecast to 2028 - Country Analysis By Type, Application, Distribution Channel, and End User - Product Thumbnail Image

US Intravenous Immunoglobulin Market Forecast to 2028 - Country Analysis By Type, Application, Distribution Channel, and End User

  • Report
  • April 2023
  • 145 Pages
  • United States
From
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more